Evaluation of the effect of 48 weeks of BIC/F/TAF and DRV/c/F/TAF on platelet function in the context of rapid ART start

Introduction The BIC-T&T study aimed to determine the efficacy of bictegravir/emtricitabine/tenofovir alafenamide (BIC/F/TAF) and darunavir/cobicistat/emtricitabine/tenofovir alafenamide (DRV/c/F/TAF) at suppressing viral load in a two-arm, open-label, multi-centre, randomised trial under a UK t...

Full description

Saved in:

Bibliographic Details
Main Authors:	Akif A. Khawaja, Gary Whitlock, Sarah Fidler, Alfredo Soler-Carracedo, Merle Henderson, Graham P. Taylor, Marta Boffito, Michael Emerson
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Series:	HIV Research & Clinical Practice
Subjects:	drv/c/f/taf bic/ftc/taf hiv infection rapid art strategy test-and-treat platelets
Online Access:	http://dx.doi.org/10.1080/25787489.2024.2447015
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Evaluation of the effect of 48 weeks of BIC/F/TAF and DRV/c/F/TAF on platelet function in the context of rapid ART start

Similar Items